高级检索
当前位置: 首页 > 详情页

A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes

文献详情

编号/登记号:
研究结束时间:
项目类型:
本院角色:
多中心研究:
招募状态:
试验分期:
研究类型:
研究参与人:
研究单位: [1]Eli Lilly and Company [2]The Second People's Hospital of Hefei,Hefei,Anhui,China,230011 [3]Beijing Hospital,Beijing,Beijing,China,100005 [4]Beijing Chaoyang Hospital, Capital Medical University,Beijing,Beijing,China,100020 [5]Beijing Pinggu District Hospital,Beijing,Beijing,China,101200 [6]Chongqing General Hospital,Chongqing,Chongqing,China,400014 [7]Huizhou Municipal Central Hospital,Huizhou,Guangdong,China,516001 [8]The First Affiliated Hospital of Harbin Medical University,Harbin,Heilongjiang,China,150001 [9]The Fourth Hospital of Harbin Medical University,Harbin,Heilongjiang,China,150001 [10]The First Affiliated Hospital of Henan University of Science &Technology,Luoyang Shi,Henan,China,471003 [11]The Second Affiliated Hospital of Zhengzhou University,Zhengzhou,Henan,China,450014 [12]The First People's Hospital of Yueyang,Yueyang,Hunan,China,414000 [13]Baotou Central Hospital,Bao Tou,Inner Mongolia,China,014040 [14]Changzhou No.2 People's Hospital,Changzhou,Jiangsu,China,213000 [15]Nanjing First Hospital,Nanjing,Jiangsu,China,210006 [16]Zhongda Hospital Southeast University,Nanjing,Jiangsu,China,210009 [17]The Second Affiliated Hospital of Nanjing Medical University,Nanjing,Jiangsu,China,210011 [18]The Affiliated Jiangyin Hospital of Southeast University Medical College,Wuxi Shi,Jiangsu,China,214400 [19]Wuxi People's Hospital,Wuxi,Jiangsu,China,214023 [20]Affiliated Hospital of Jiangsu University,Zhenjiang,Jiangsu,China,212000 [21]The Third Hospital of Nanchang,Nanchang,Jiangxi,China,330009 [22]Jiangxi Pingxiang People's Hospital,Pingxiang,Jiangxi,China,337055 [23]The First Affiliated Hospital of Xi'an Medical University,Xi'an,Shaanxi,China,710077 [24]Jinan Central Hospital,Jinan,Shandong,China,250013 [25]West China Hospital of Sichuan University,Cheng Du,Sichuan,China,610041 [26]Chengdu Fifth People's Hospital,Chengdu,Sichuan,China,611130 [27]Tianjin Medical University General Hospital,Tianjin,Tianjin,China,300052 [28]Tianjin Medical University Zhu Xianyi Memorial Hospital,Tianjin,Tianjin,China [29]The First People's Hospital of Yunnan Province,Kunming,Yunnan,China,650034 [30]Huzhou Central Hospital,Huzhou,Zhejiang,China,313000

研究目的:
The main purpose of this study is to compare the effect of the addition of tirzepatide or placebo to titrated basal insulin on glycemic control in Chinese participants with type 2 diabetes.

资源点击量:82521 今日访问量:0 总访问量:681 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 云南省第一人民医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西山区金碧路157号